Idiopathic Intracranial Hypertension: Clinical Features and Diagnostic Criteria

Core Clinical Features

The American Academy of Neurology recommends that idiopathic intracranial hypertension (IIH) is characterized by papilledema, elevated intracranial pressure (≥25 cm H₂O on lumbar puncture), and normal neuroimaging, typically affecting obese women of childbearing age with BMI >30 kg/m² 1, 2
Papilledema is the hallmark finding in IIH and must be documented on fundoscopic examination 2
Transient visual obscurations (unilateral or bilateral darkening of vision lasting seconds) occur commonly in patients with IIH 1, 2
Visual field defects develop in many patients with IIH and require serial monitoring 1
Progressive visual loss can occur if IIH is left untreated, representing the most serious morbidity of the condition 1
Headache is the most common presenting symptom of IIH, occurring in 92% of patients 3
The headache phenotype in IIH is highly variable and may mimic other primary headache disorders (migraine, tension-type), making clinical diagnosis challenging 1, 2
Horizontal diplopia from sixth nerve palsy is the typical cranial nerve finding in IIH 1, 2
If other cranial nerves are involved beyond the sixth nerve, alternative diagnoses should be strongly considered 2
Pulsatile tinnitus (whooshing sound synchronous with pulse) is a common symptom in IIH 1, 2

Urgent MRI brain within 24 hours is the first step in diagnosing IIH; if unavailable, perform urgent CT brain followed by MRI 2, 4
Imaging must show no hydrocephalus, mass, structural or vascular lesion, and no abnormal meningeal enhancement in patients with IIH 2
CT or MR venography is mandatory within 24 hours to exclude cerebral sinus thrombosis in patients with suspected IIH 2, 4
CSF opening pressure must be ≥25 cm H₂O measured in the lateral decubitus position to diagnose IIH 2, 4
Proper technique is essential for lumbar puncture: patient in lateral decubitus position, legs extended, relaxed, breathing normally, with measurement taken after pressure stabilizes 2

The typical IIH profile is characterized by female sex, childbearing age, and BMI >30 kg/m² 2, 3
Patients not fitting the typical demographic profile require more in-depth investigation for IIH 2
Non-obese prepubertal children warrant particular consideration for cerebral venous sinus thrombosis 2

Severe papilledema at presentation is a negative prognostic factor for IIH 3
Weight loss of 5-15% of body weight may lead to disease remission in IIH 3
IIH may recur throughout life, particularly with weight regain or hormonal changes including pregnancy 3

Severe papilledema requires monitoring every 1-3 months in patients with IIH 3
More frequent monitoring is needed if visual function is worsening, with immediate assessment required for worsening with severe papilledema 3
Repeat lumbar puncture should be performed if significant deterioration of visual function occurs to reassess CSF pressure in patients with IIH 2

Failing to recognize that headache phenotype can mimic primary headache disorders, delaying diagnosis of IIH 1, 2
Improper lumbar puncture technique leading to inaccurate opening pressure measurements in patients with IIH 2
Assuming normal intracranial pressure on a single measurement when pressure can fluctuate in IIH 2
Failing to perform venography to exclude cerebral sinus thrombosis in patients with suspected IIH 2, 4
Not recognizing that headaches often persist despite successful treatment of elevated ICP in IIH 3

Intracranial venous hypertension is a prominent feature of idiopathic intracranial hypertension (IIH), with transverse sinus stenosis frequently identified on neuroimaging studies. 5

A strong epidemiologic link exists between obesity and IIH; the condition is increasingly common alongside the global obesity epidemic and predominantly affects women with a body‑mass index > 30 kg/m². 5
The observed association has driven metabolic theories that propose adipose‑tissue dysfunction as a mechanistic contributor to elevated intracranial pressure in IIH. 5

Because of the complex and multifactorial pathophysiology, IIH diagnosis mandates exclusion of secondary causes through comprehensive neuroimaging that includes venography to assess for venous sinus abnormalities. 5

Impaired cerebrospinal fluid (CSF) homeostasis increases CSF volume in the subarachnoid space, initiating intracranial pressure (ICP) elevation (≥ 25 cm H₂O) 6.
Transverse‑sigmoid sinus stenosis diminishes cerebral venous outflow through the internal jugular veins, contributing to venous hypertension 6.
The reduction in venous drainage further impedes CSF absorption, causing additional CSF accumulation and a self‑reinforcing rise in ICP 6.

Between 38 % and 45 % of individuals with IIH experience symptom worsening or recurrence within 6–10 years despite optimal medical therapy [7][8].

Carbonic anhydrase inhibition (e.g., acetazolamide) decreases CSF production, thereby lowering ICP 7.
Transverse‑sigmoid sinus stenting mechanically restores sinus patency, improves venous drainage, and interrupts the compression‑stenosis feedback loop [7][8].

Venous manometry is recommended as the gold‑standard test to quantify the physiologic significance of sinus stenosis before undertaking stenting, acknowledging the bidirectional causality between stenosis and elevated ICP [7][8].